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THE EFFICACY OF ORAL GLUTAMINE AS A PRELOADED MEDICINE IN RE-
DUCING THE SEVERITY AND DURATION OF MUCOSITIS IN THE PEDIAT-
RIC STEM CELL TRANSPLANT SETTING
Garee, A.M., Termuhlen, A.M., Skeens, M.A., Rosselet, R.M., Ryan-
Wenger, N. Nationwide Childrens Hospital, Columbus, OH
Objectives: (1) To compare the severity and duration of mucositis
during myeloablative hematopoietic stem cell transplant (HSCT) in
patients receiving glutamine starting 2 weeks prior to preparative
therapy vs. historical controls using standard mouth care without
glutamine. (2) To determine the feasibility of preloading glutamine
in pediatric patients.
Background: Mucositis is a highly debilitating complication of
myeloablative HSCT. It is associated with pain, poor oral nutri-
tional intake, diarrhea, and increased risk of infections due to
poor mucosal integrity. A randomized, placebo-controlled pediat-
ric trial demonstrated decreased mucositis scores, narcotic use,
and days of TPN with glutamine supplementation beginning
with HSCT preparative therapy (Aquino, VM (2005) a pediatric
blood and marrow transplant consortium study. Bone Marrow
Transplant Oct 36;611–6). Based on the results of that trial and
the mechanism of action of glutamine, we tested the feasibility
and efficacy of starting glutamine supplementation 2 weeks prior
to the preparative regimen.
Methods: The glutamine group (N 5 25, sequential patients)
received 2 grams/m2 qid swish and swallow of glutamine (500
mg/ml suspension) for 14 days prior to and throughout HSCT
admission. The historical control group (N 5 25, sequential
patients) received standard mouth care without glutamine begin-
ning on admission for HSCT. Data was obtained from retrospec-
tive chart review. Outcome measures include days of TPN, days
of intravenous narcotics, length of hospital stay, and mucositis
scoring.
Results:All patients preloaded with glutamine completed 14 days.
Analysis of the historical control group showed a mean of 36 days of
TPN use , a mean of 28 days of narcotic use, a mean of 49 days of
hospital stay and a mean mucositis score of 3. Data collection for
the glutamine group and the statistical analysis will be completed
in November.
Conclusions: Pediatric patients were able to complete 14 days of
glutamine prior to HSCT admission. We will report the efficacy of
glutamine compared to the historical control at the meeting. If the
glutamine group has decreased morbidity during HSCT (measured
by mucositis scores, days of narcotics, days of TPN, length of stay),
we will test the efficacy of the preloaded glutamine vs. glutamine
started concurrently with preparative therapy in a prospective ran-
domized trial.76
LONG-TERM FOLLOW-UP OF PATIENTS AFTER ALLOGENEIC HEMATO-
POIETIC STEM CELL TRANSPLANTATION (HSCT) WITH REGARD TO
QOL AND SOCIAL FUNCTIONING IN CHRONIC GVHD: A SINGLE-
INSTITUTE ANALYSIS
Mori, A.1, Yamada, M.2, Wada, N.2, Fujii, E.2, Mori, M.2,
Tanosaki, R.2, Yamamoto, S.1, Araki, M.2, Takaue, Y.2 1National Cancer
Center, Tokyo, Japan; 2National Cancer Center Hospital, Tokyo, Japan
Purpose: A single-institute evaluation of patients who underwent
allogeneic HSCT with regard to QOL, social functioning and
chronic GVHD was performed to identify a suitable long-term fol-
low-up system that is compatible with the Japanese medical environ-
ment and society.
Methods: The subjects were patients who underwent myeloabla-
tive allogeneic HSCT at our institute between January 1999 and De-
cember 2007, and who were still surviving disease-free. Chronic
GVHD was evaluated by each attending physician with the use of
NIH-GVHD. QOL was self-recorded by the patients according to
SF-36 ver2.0, FACT-BMT and FACIT-Sp12. Changes in social
function were evaluated in terms of the working status as a landmark.
This study was approval by the IRB and consent was obtained from
all patients.Results:During the study period, a total of 52 patients met the
enrollment criteria and complete data were obtained from 50 pa-
tients (96.2%) for the analysis. There were 23 males and 27 fe-
males (median age, 41 years; range, 19–56 years), with
a median follow-up of 3.6 years (0.5–8.9 years). Twenty-one pa-
tients underwent related PBSCT and 29 patients underwent
BMT (related 4, unrelated 25). Chronic GVHD was observed
in 40 patients, with an average NIH-GVHD score of 3.6 (0–
13), predominantly in the mouth and eyes. Patients who had
scores of ‘‘none’’ or ‘‘mild’’ were classified as the ‘‘observation
group’’ (23 patients, 46%), while those with ‘‘moderate’’ and ‘‘se-
vere’’ findings were classified as the ‘‘treatment group’’ (27,
54%). With regard to QOL, all of the average SF-36 subscales
were below Japanese standards. The median period required to
return to their original job was 12 months (2–24 mo), and 12 pa-
tients (24%) had variable changes in the labor status, which were
significantly related to the degree of NIH-GVHD. Factors that
significantly affected the changes in labor status and degree of
NIH-GVHD included 1) ‘‘physical functioning’’, ‘‘general
health perceptions’’ and ‘‘social functioning’’ for SF-36, 2) ‘‘total
score’’, ‘‘functional well-being’’, ‘‘emotional well-being’’ and
‘‘BMT-score’’ for FACT-BMT, and 3) ‘‘total score’’ and ‘‘mean-
ing/peace’’ for FACIT-Sp12.
Discussion: This study confirmed that NIH-GVHD may be use-
ful in the initial risk-adjusted stratification of patients for subsequent
psychosocial/spiritual follow-up and intervention in a country which
has different clinical manifestations of GVHD and a different med-
ical/social environment than in the US.77
STORIES AND MUSIC FOR ADOLESCENT/YOUNG ADULT: RESILIENCE
DURING TRANSPLANT
Haase, J.A.1, Robb, S.L.2, Burns, D.S.3, Stegenga, K.4, Haut, P.R.5,
Rimkus, C.6 1 Indiana University/ Perdue University in Indianapolis, In-
dianapolis, IN; 2 Indiana University/Perdue University in Indianapolis,
Indianapolis, IN; 3Purdue School of Engineering and Technology @ IU-
PUI, Indianapolis, IN; 4Children’s Mercy Hospital, Kansas City, MO;
5 Indiana Universtiy, Indainapolis, IN; 6Barnes-Jewish Hospital, Siteman
Cancer Center, St. Louis, MO
Adolescents and young adults (AYA) have unique concerns and
needs compared to older adults undergoing Stem Cell Transplant
(SCT). A randomized clinical trial is underway to determine if
the development of a Therapeutic Music Video (TMV) can help
AYAs (ages 11 to 24) gain resilience as an outcome of SCT. Resil-
ience is defined as positive adjustment in the face of adversity. The
study’s conceptual model identifies resources such as family envi-
ronment, adaptive coping, and social support that interact to de-
crease defensive coping, symptom distress, and uncertainty. The
TMV intervention may help AYAs undergoing SCT use music
and lyrics as a way to reflect on and work through cancer related
distresses. The major hypotheses of this study are that when com-
pared to the low-dose control, study participants who receive the
TMV will have decreased uncertainty and symptom distress and in-
creased family adaptability/cohesion and communication, perceived
social support, adaptive coping, hope, spiritual perspective, resil-
ience and quality of life. This study, administered from Indiana
University, is a cooperative effort among 3 adult and 6 children’s
hospitals at 6 medical centers across the country. Currently 80
AYA undergoing SCT have been enrolled in the study; the target
sample is 175. Participants are randomized to the TMV or audio
books condition. Regardless of group assignment, over a 3week
time period, participants have 6 one-hour meetings with a board-
certified music therapist. With help from trained evaluators, partic-
ipants also complete QOL questionnaires accessed through secure
web-sites on laptop computers. In the adult setting, clinical trials of
behavioral interventions targeting young adults (YA) are rarely
done. There are both challenges and benefits to conducting such
studies in adult hospitals. For example, AYA who are married or
have children are not eligible for the study, because their illness re-
lated concerns may be very different. A benefit is access to the re-
source of a board-certified music therapist, which may not be as
readily available in adult hospitals; both staff and the AYA patients
have enjoyed the addition of music therapy and staff have gained
opportunities to understand this patient population through their
